MeVis Medical Solutions AG (ETR:M3V)
Germany flag Germany · Delayed Price · Currency is EUR
24.80
+0.20 (0.81%)
Feb 13, 2026, 5:35 PM CET

ETR:M3V Cash Flow Statement

Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Net Income
3.174.564.927.794.55
Depreciation & Amortization
0.150.130.10.090.13
Other Operating Activities
-0.87-1.07-0.46-1.62-0.25
Change in Accounts Receivable
0.640.571.58-1.913.9
Change in Accounts Payable
0.76-0.130.05-0.270.34
Change in Other Net Operating Assets
0.04-0.91-0.320.770.46
Operating Cash Flow
3.883.155.854.869.13
Operating Cash Flow Growth
23.29%-46.25%20.52%-46.80%215.97%
Capital Expenditures
-0.14-0.3-0.08-0.13-0.05
Investment in Securities
-0.01---
Other Investing Activities
1.091.21.070.190.16
Investing Cash Flow
0.950.910.990.060.11
Other Financing Activities
-4.56-4.92-7.79-4.55-5.7
Financing Cash Flow
-4.56-4.92-7.79-4.55-5.7
Foreign Exchange Rate Adjustments
-0.27-0.35-0.631.330.13
Net Cash Flow
-0-1.22-1.581.73.67
Free Cash Flow
3.742.845.774.729.08
Free Cash Flow Growth
31.44%-50.74%22.23%-47.97%225.78%
Free Cash Flow Margin
23.28%16.76%33.30%25.18%56.00%
Free Cash Flow Per Share
2.051.563.172.604.99
Cash Interest Paid
----0
Cash Income Tax Paid
0.110.290.120.170
Levered Free Cash Flow
1.912.364.282.759.07
Unlevered Free Cash Flow
1.912.374.282.759.07
Change in Working Capital
1.44-0.471.3-1.414.71
Source: S&P Global Market Intelligence. Standard template. Financial Sources.